Primary Myelofibrosis Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02251821JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisTreatment
NCT01384513A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesTreatment
NCT03303950Busulfan, Fludarabine, Donor Stem Cell Transplant, and Cyclophosphamide in Treating Patients With Multiple Myeloma or MyelofibrosisTreatment
NCT01760655Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment